Short answer
Gilead Sciences (GILD) filed an 8-K current report with the SEC on May 20, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation), Item 8.01 (Other Events). $3.0B senior-note issuance across 2028, 2029, 2031 and 2034 maturities.
Gilead Sciences 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $3.0B senior-note issuance across 2028, 2029, 2031 and 2034 maturities
- Fixed semiannual coupons ranging from 4.250% to 4.900%
- Proceeds designated for acquisitions, investments, strategic transactions or general corporate purposes
- Added interest expense and refinancing obligations through 2034
- Covenants limit secured debt, sale-leasebacks and certain asset transfers; change-of-control repurchase provisions apply
Item 2.03 · Creation of a Direct Financial Obligation
- Item 2.03 signals a new direct financial obligation or off-balance-sheet arrangement
Item 8.01 · Other Events
- Gilead entered an underwriting agreement on May 14, 2026, for issuance and sale of debt notes
- Barclays, BofA Securities and Citigroup acted as underwriter representatives
- Offering conducted under Gilead’s effective Form S-3 shelf registration, enabling capital-market access
- Underwriting agreement and counsel opinion filed as Exhibits 1.1 and 5.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Gilead Sciences 8-K filings
Get the next GILD 8-K as it lands
Follow GILD for push alerts, or ask the research agent what this filing means.